phenoxybenzamine has been researched along with icatibant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH | 1 |
| Damas, J; Hallet, C; Lefebvre, PJ | 1 |
2 other study(ies) available for phenoxybenzamine and icatibant
| Article | Year |
|---|---|
Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biphenyl Compounds; Blood Pressure; Bradykinin; Diclofenac; Dogs; Epinephrine; Female; Imidazoles; Losartan; Muscle Denervation; Muscles; Norepinephrine; Phenoxybenzamine; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles | 1993 |
Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Epinephrine; Insulin; Male; Phenoxybenzamine; Phentolamine; Propranolol; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptors, Bradykinin | 2001 |